(
171
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Aeroallergen exposure and climate change: challenges and solutions
-
Allergenicity and IgE recognition of new Dau c 1 allergens from carrot
-
Allergy Training in Europe: Challenges in our speciality
-
Challenges in clinical allergy
-
Challenges in food allergy management
-
EAACI & ERS joint symposium: new ERS clinical guidelines on diagnosis of asthma in school children
-
EAACI & JSA joint symposium: new aspects of allergic diseases in mucosal tissue
-
Endotyping occupational asthma: progress and challenges in current practice
-
Food allergy: new allergens on the block
-
New Epidemiologic Factors Related to allergy and asthma
-
New Perspectives on Allergen Immunotherapy
-
New Perspectives on Allergen Immunotherapy
-
New and clinically relevant contact allergens
-
New insights in urticaria mechanisms
-
New mechanisms for chronic diseases
-
New visions for managing anaphylaxis. Lesson from EAACI guidelines
-
Opportunities and Obstacles to treat severe asthma with new biologics based on experiences from real world practice
-
Oral food challenge versus biomarkers – are challenges still needed?
-
Oral food challenges thresholds for clinical reactions
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Pru p 10: the polygalacturonase described as a new peach tree pollen allergen
-
What is the immunological basis for new biologicals?
Show more Event Resources (20)Show Less-
-
“Allergen Harmony”: New data for a tailored and sustained food and respiratory immunotherapy effect
-
A New Age in the Management of Pediatric Atopic Dermatitis: Evolution of Disease Understanding and Treatment Opportunities
-
Activated phosphoinositide 3-kinase δ syndrome (APDS): Challenges in diagnosis, management and recent advances in treatment
-
Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options
-
Breaking new ground: A closer look at Type 2 Inflammation in pediatric asthma
-
Expanding AIT evidence with new phase III clinical data in children with respiratory allergy
-
Exploring new horizons: The future of Hereditary Angioedema treatment
-
Mind the PAF: a new route to managing chronic urticaria and allergic diseases?
-
Pioneering a new age – fighting allergic disease on all fronts!
-
SCIT; pioneering a new era
-
Setting a new standard for grass subcutaneous immunotherapy
-
Treating peanut allergy with oral immunotherapy: new data and practical experience
Show more Sponsored Symposia (10)Show Less-
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy
-
EAACI Position paper on the standardization of nasal allergen challenges
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document
-
Eosinophils – from cradle to grave: An EAACI task force paper on new molecular insights and clinical functions of eosinophils and the clinical effects of targeted eosinophil depletion
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research – The European Strategic Forum on Allergic Diseases
Show more Position Papers (3)Show Less-
Website
Collapse
-
A New Immunotoxin Design against Allergy Based on the IL33 Cytokine and the Ribotoxin α-Sarcin
-
A New Immunotoxin Design against Allergy Based on the IL33 Cytokine and the Ribotoxin α-Sarcin
-
A new tryptase gene haplotype in human associates alpha-triplication and beta-deletion
-
ALK – Expanding AIT evidence with new phase III clinical data in children with respiratory allergy
-
Adult-onset food protein-induced enterocolitis syndrome. Cytokine variations after positive oral food challenges
-
Aging and hereditary angioedema: use of new long-term prophylactic therapies in the geriatric population
-
Allergy Therapeutics – Setting a new standard for grass subcutaneous immunotherapy
-
Allergy to anesthetics: new insights in diagnosis and risk reduction
-
Anti-microbial peptides – a new class of allergens?
-
Are LADDERS the new Oral Food Challenge?
-
Are oral food challenges still necessary for diagnosing food allergy
-
Assessing protocol variability for FPIES oral food challenges
-
Assessing risk for food challenges
-
Assessment of milk and egg ladder in real-world settings: Parental perspectives on challenges and opportunities for enhancement
-
Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies
-
BioCryst – Reimagining hereditary angioedema (HAE) care – is it time to define the new ‘normal’ for patients with HAE?
-
Chalcones: butein and licochalcone A are promising new agents in the inhibition of asthma-related profibrotic TGF-β1-dependent processes
-
Challenges in Anaphylaxis Diagnosis: a 6-year evaluation
-
Challenges in Anaphylaxis management
-
Challenges in Biologics for Chronic Rhinosinusitis with Nasal Polyps
-
Challenges in Egg Allergy – A Retrospective Look at the Utility of Cut-off Values
-
Challenges in occupational and environmental allergy
-
Challenges in the treatment of CRSwNP with biologics
-
Challenging the Norm: Rethinking the relevance of Cefixime challenges in confirmed penicillin-allergic patients
-
Characterization of adaptative immune cells after double-blind placebo-controlled oral food challenges
-
Chicken egg allergy: development of new egg white allergoids
-
Childhood mastocytosis: challenges in clinical practice
-
Chronic Urticaria: challenges in childhood
-
Chronic rhinosinusitis with nasal polyposis: an old problem with a new solution
-
Clearing the Air: How Vidian Neurectomy Offers New Hope for Stubborn Allergic Rhinitis
-
Climate change and new occupational allergens
-
Contact Dermatitis, an update on New Contact Allergens and How to Patch Test
-
Demystifying CSU: Diagnostic challenges and practical insights
-
Development of a new method to generate transduced dendritic cells expressing MART-1 antigen by employing Lentivirus vectors
-
Development of standardised challenge meals to meet regulators demands for Oral Food Challenges
-
Diagnosing LTP Allergy: Challenges and Innovations
-
Discovering new horizons in allergen immunotherapy
-
EAACI & CIA JOINT SYMPOSIUM : Shaping the Future of Allergy Research: Showcasing New Leaders in the Collegium Internationale Allergologicum (CIA)
-
Emulsion containing a new chitosan derivative versus petrolatum in children with mild atopic dermatitis: a randomised controlled trial
-
Eosinophilic Esophagitis in Children: Challenges and Solutions in Dietary Therapy
-
Expanding the evidence for the SQ house dust mite SLIT-tablet in younger children with house dust mite allergic rhinitis – new phase III results
-
Expanding the evidence for the SQ tree SLIT-tablet in children with tree pollen allergic rhinoconjunctivitis – new phase III results.
-
Exploiting HAE pathophysiology for the identification of new therapeutic targets
-
Exploring Uncharted Territories: New Cells and Their Impact on Mucosal Immunity
-
Food challenges in non-clinical settings
-
Global Stage Session 3 – Successes and challenges of Immunotherapy
-
HEAD registry – new horizons
-
How should we be putting the new food allergy diagnosis guidelines into practice?
-
Identification of gibberellin-regulated protein as a new allergen in strawberry allergy
-
Identification of new allergens in macadamia nut and cross-reactivity with other tree nuts in a Spanish cohort
-
Impact of the new UK guidelines on the emergency management of anaphylaxis at two hospitals
-
Insights into allergy Cross-reactions and diagnostic challenges
-
Introduction of the new EAACI President
-
Ionis Pharmaceuticals – Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options
-
Key challenges in endpoints of clinical trials in AIT- Clinical vs mechanistic parameters
-
Multi-omic analyses reveal new potential biomarkers for monitoring asthmatic patients treated with either Mepolizumab or Omalizumab
-
Multi-omic analyses reveal new potential biomarkers for monitoring asthmatic patients treated with either Mepolizumab or Omalizumab
-
Multiple food protein-induced enterocolitis syndrome in a child with 8 positives oral food challenges
-
NERD: new diagnostic and therapeutic approaches
-
Nasal Allergen Challenges in the clinical setting: Experience of a centre
-
Navigating the New Guidelines: Implications for Patients and Their Families
-
New EAACI Food Allergy Guidelines
-
New Frontiers in Respiratory Allergy
-
New Insights Into Hypereosinophilia and Hypereosinophilic Syndromes Thanks To The First 550 Patients Included In The COHESion Study, A National Multicenter Cohort
-
New allergens approved by the WHO/IUIS Allergen Nomenclature Sub-Committee in 2021-2023
-
New and emerging therapies for long-term prophylaxis in HAE
-
New clinical nomenclature for CRS
-
New directions in immunotherapy and vaccinology
-
New grading of Vernal keratoconjunctivitis based on clinical profile of 1049 Vernal Keratoconjunctivitis patients
-
New horizons in skin disorders
-
New insights in pathogenesis of atopic dermatitis
-
New mechanisms of anaphylaxis
-
New treatment options in childhood atopic dermatitis
-
Opening and Introductions: Challenges with Delays in On-demand Treatment
-
Opportunity and challenges
-
Oral Food Challenges in Children’s Health Ireland
-
Organ RNA profiles exploration in an active anaphylactic mice model with repeated challenges
-
Outcomes of low-dose peanut food challenges in preschoolers when initiating peanut oral immunotherapy
-
Prognostic markers for drug challenges in non-steroidal anti-inflammatory drugs
-
Prognostic markers for drug challenges in non-steroidal anti-inflammatory drugs
-
Rational for the new nomenclature and basic principles
-
Refractory avocado anaphylaxis, what are we missing about it; new allergens?
-
Sanofi : What’s New in CRSwNP? Real-Life Experiences and Current Treatment Goals
-
Sensory validation of food recipes for double-blind placebo-controlled food challenges
-
Stallergenes Greer – “Allergen Harmony”: New data for a tailored and sustained food and respiratory immunotherapy effect
-
Successes and challenges of Immunotherapy
-
Successes and challenges of Immunotherapy
-
Successes and challenges of Immunotherapy
-
Successes and challenges of Immunotherapy in Poland and EU
-
Takeda – HAE and pregnancy: navigating the challenges
-
Targeted drug-induced apoptosis in key cellular mediators of allergic asthma as a new treatment strategy
-
The Impact of Climate Change on Food Allergies: Challenges and Adaptations
-
The Role of Oral Food Challenges in Clinical Trials: Necessity or Redundancy?
-
The journey to registration: challenges for allergen immunotherapy trials
-
The new nomenclature for asthma and allergy
-
The new nomenclature – from bench to implementation in the clinic
-
The new nomenclature – rationale and basic principles
-
The puzzling journey of asthma diagnosis – the IPCRG’s new educational approach.
-
The role of IFN-γ in pediatric non-IgE-mediated gastrointestinal food allergy: new results from NIGEFA Project
-
The role of IFN-γ in pediatric non-IgE-mediated gastrointestinal food allergy: new results from NIGEFA Project
-
The role of skin testing, serum IgE, and extended oral challenges in diagnosing childhood beta-lactam allergy: The CHildren Antibiotic Delabeling (CHAD) study
-
Thunderstorm-related respiratory symptoms: an old story with a new ending?
-
Trans-ethnic analysis in over 780,000 individuals yields new insights into the genetic etiology of allergic diseases
-
Ultraprocessed foods induce in situ differentiation of eosinophils in the esophageal mucosa: new insights for the pathogenesis of pediatric eosinophilic esophagitis
-
Ultraprocessed foods induce in situ differentiation of eosinophils in the esophageal mucosa: new insights for the pathogenesis of pediatric eosinophilic esophagitis
-
Update on Food Challenges
-
Urinary PGDM is not elevated during oral food challenges for food protein-induced enterocolitis syndrome
-
Validation of objective stopping criteria of double-blind placebo-controlled food challenges and its influencing factors in IgE-mediated food allergy
-
Validation of objective stopping criteria of double-blind placebo-controlled food challenges and its influencing factors in IgE-mediated food allergy
-
Voice biomarkers: a new tool for asthma management
-
What advice should we give new parents to prevent food allergy?
-
What is new in dietary elimination for EoE?
-
What’s new in CRSwNP? Real-Life experiences and current treatment goals
-
Why So Sensitive? Identifying New Allergic Sensitization in Patients On Subcutaneous Immunotherapy (SCIT)
-
RHINA : Allergic rhinitis: new challenges and new opportunities
Show more Sessions (113)Show Less-
-
EAACI Presidential message – New Year’s Greetings
-
Introducing The New EAACI Review 06: Reflecting on 2023 and Looking Forward to a Promising 2024!
-
Introducing The New EAACI Review 07: Committed to your health
-
Introducing The New EAACI Review: A Gateway to Cutting-Edge Research in Allergy and Clinical Immunology
-
New Adaptive Trial Design Supports Evaluation of Therapeutic Strategies for Allergic Patients
-
New Clinical Guidelines for the Diagnosis of Immediate-type Food Allergies are launched
-
New EAACI Paper: Immune-mediated disease caused by climate change-associated environmental hazards: mitigation and adaptation
-
New Study Reveals Potential Link between Mast Cell Activation and Neoantigen Load in Cancers
Show more News (6)Show Less-